Key Insights

Highlights

Treatment Research

2 treatments under study, led by Data Collection

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06537427UnknownPrimary

The Crosstalk Between the Epigenome and Mitochondria in SCI

NCT03762655Not ApplicableTerminatedPrimary

Study of Probable Benefit of the Neuro-Spinal Scaffold™ in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care

Showing all 2 trials

Research Network

Common Treatments

  • Data Collection1
  • Neurospinal Scaffold1

Active Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • InVivo Therapeutics1

Activity Timeline